Regarding the literature on sPDGFRβ, some studies have shown that sPDGFRβ was increased in AD [27] and linked to APOE4-status [26], other studies reported an association with cognitive dysfunction irrespective of AD-pathology [18]. The gene discussed is APOE; the disease is Alzheimer disease.